• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症性肠病患者体内促动脉粥样硬化炎症介质增加血栓形成、冠状动脉疾病和心肌梗死风险:一个科学难题。

Pro-Atherogenic Inflammatory Mediators in Inflammatory Bowel Disease Patients Increase the Risk of Thrombosis, Coronary Artery Disease, and Myocardial Infarction: A Scientific Dilemma.

作者信息

Kondubhatla Kaushik, Kaushal Ayush, Daoud Ali, Shabbir Hassan, Mostafa Jihan A

机构信息

Internal Medicine, California Institute of Behavioral Neurosciences and Psychology, Fairfield, USA.

Psychiatry and Behavioral Sciences, California Institute of Behavioral Neurosciences and Psychology, Fairfield, USA.

出版信息

Cureus. 2020 Sep 19;12(9):e10544. doi: 10.7759/cureus.10544.

DOI:10.7759/cureus.10544
PMID:33062549
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7549854/
Abstract

Inflammatory bowel disease (IBD), comprising ulcerative colitis and Crohn's disease, is characterized by widespread inflammation of the gastrointestinal tract with systemic manifestations. Inflammation is one of the driving forces for the pathogenesis of atherosclerosis and its dreaded complications like myocardial infarction (MI). Yet, the association between IBD and myocardial infarction has not been thoroughly established. Myocardial infarction in IBD patients was predominantly seen in young women during the active disease process. At the same time, elevated levels of C-reactive protein and other pro-inflammatory markers were observed in both IBD and atherosclerosis. Increasing evidence suggests inflammation inhibits fibrinolysis, expresses procoagulants, and suppresses anticoagulants promoting thrombosis formation. Moreover, the alteration of gut microbiota impacts the pathogenesis of inflammation and predisposes one to ischemic heart disease. Accordingly, all IBD patients should be screened and counseled on lifestyle modifications for the traditional risk factors of atherosclerosis. Future researchers should consider conducting more clinical trials on anti-inflammatory medication targeting atherosclerosis and therapeutics, while targeting the gut microbiota to reverse the inflammatory atherosclerotic process.

摘要

炎症性肠病(IBD)包括溃疡性结肠炎和克罗恩病,其特征是胃肠道广泛炎症并伴有全身表现。炎症是动脉粥样硬化及其可怕并发症(如心肌梗死(MI))发病机制的驱动因素之一。然而,IBD与心肌梗死之间的关联尚未完全确立。IBD患者的心肌梗死主要发生在疾病活动期的年轻女性中。同时,在IBD和动脉粥样硬化患者中均观察到C反应蛋白及其他促炎标志物水平升高。越来越多的证据表明,炎症会抑制纤维蛋白溶解、表达促凝剂并抑制抗凝剂,从而促进血栓形成。此外,肠道微生物群的改变会影响炎症的发病机制,并使人易患缺血性心脏病。因此,所有IBD患者都应接受筛查,并就动脉粥样硬化传统危险因素的生活方式改变接受咨询。未来的研究人员应考虑针对动脉粥样硬化和治疗方法开展更多关于抗炎药物的临床试验,同时针对肠道微生物群来逆转炎症性动脉粥样硬化进程。

相似文献

1
Pro-Atherogenic Inflammatory Mediators in Inflammatory Bowel Disease Patients Increase the Risk of Thrombosis, Coronary Artery Disease, and Myocardial Infarction: A Scientific Dilemma.炎症性肠病患者体内促动脉粥样硬化炎症介质增加血栓形成、冠状动脉疾病和心肌梗死风险:一个科学难题。
Cureus. 2020 Sep 19;12(9):e10544. doi: 10.7759/cureus.10544.
2
Risk of Myocardial Infarction in Inflammatory Bowel Disease: A Population-based National Study.炎症性肠病患者心肌梗死的风险:一项基于人群的全国性研究。
Inflamm Bowel Dis. 2019 May 4;25(6):1080-1087. doi: 10.1093/ibd/izy354.
3
Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome.炎症性肠病(IBD)中肠道微生物群的改变:原因还是后果?针对肠道微生物群的IBD治疗靶点
Pathogens. 2019 Aug 13;8(3):126. doi: 10.3390/pathogens8030126.
4
Inflammatory bowel disease as a risk factor for premature coronary artery disease.炎症性肠病作为早发性冠状动脉疾病的一个风险因素。
J Clin Med Res. 2015 Apr;7(4):257-61. doi: 10.14740/jocmr2102w. Epub 2015 Feb 9.
5
Gut microbiota in the pathogenesis of inflammatory bowel disease.肠道微生物群在炎症性肠病发病机制中的作用
Clin J Gastroenterol. 2018 Feb;11(1):1-10. doi: 10.1007/s12328-017-0813-5. Epub 2017 Dec 29.
6
Ischemic Heart Disease in Patients with Inflammatory Bowel Disease: Risk Factors, Mechanisms and Prevention.炎症性肠病患者的缺血性心脏病:危险因素、机制与预防
Life (Basel). 2022 Jul 24;12(8):1113. doi: 10.3390/life12081113.
7
Functional Characterization of Inflammatory Bowel Disease-Associated Gut Dysbiosis in Gnotobiotic Mice.无菌小鼠中炎症性肠病相关肠道菌群失调的功能特征
Cell Mol Gastroenterol Hepatol. 2016 Mar 3;2(4):468-481. doi: 10.1016/j.jcmgh.2016.02.003. eCollection 2016 Jul.
8
Conventional risk factors and cardiovascular outcomes of patients with inflammatory bowel disease with confirmed coronary artery disease.炎症性肠病合并确诊冠心病患者的传统危险因素及心血管结局
Inflamm Bowel Dis. 2014 Sep;20(9):1593-601. doi: 10.1097/MIB.0000000000000109.
9
Risk of cardiovascular disease in inflammatory bowel disease.炎症性肠病患者患心血管疾病的风险
Exp Ther Med. 2017 Feb;13(2):395-400. doi: 10.3892/etm.2016.3966. Epub 2016 Dec 12.
10
Cardiovascular Comorbidities and Inflammatory Bowel Disease: Causes and Consequences.心血管合并症与炎症性肠病:病因与后果
Gastroenterol Hepatol (N Y). 2024 Apr;20(4):204-215.

引用本文的文献

1
IL-12α deficiency attenuates pressure overload-induced cardiac inflammation, hypertrophy, dysfunction, and heart failure progression.白细胞介素-12α 缺乏可减轻压力超负荷引起的心脏炎症、肥大、功能障碍和心力衰竭进展。
Front Immunol. 2023 Feb 13;14:1105664. doi: 10.3389/fimmu.2023.1105664. eCollection 2023.
2
Evaluation of adalimumab effects on left ventricle performance by echocardiography indexes among patients with immunosuppressant refractory ulcerative colitis.通过超声心动图指标评估阿达木单抗对免疫抑制剂难治性溃疡性结肠炎患者左心室功能的影响。
Front Med (Lausanne). 2023 Jan 6;9:1008711. doi: 10.3389/fmed.2022.1008711. eCollection 2022.
3
Platelet Mass Index and Other Platelet Parameters in the Assessment of Inflammatory Bowel Diseases Activity.血小板质量指数及其他血小板参数在炎症性肠病活动度评估中的应用
Curr Health Sci J. 2021 Oct-Dec;47(4):566-574. doi: 10.12865/CHSJ.47.04.13. Epub 2021 Dec 31.

本文引用的文献

1
Gut microbiota and cardiovascular disease: opportunities and challenges.肠道微生物群与心血管疾病:机遇与挑战。
Microbiome. 2020 Mar 14;8(1):36. doi: 10.1186/s40168-020-00821-0.
2
Inflammatory bowel disease and the risk for cardiovascular disease: Does all inflammation lead to heart disease?炎症性肠病与心血管疾病风险:所有炎症都会导致心脏病吗?
Trends Cardiovasc Med. 2020 Nov;30(8):463-469. doi: 10.1016/j.tcm.2019.10.001. Epub 2019 Oct 11.
3
The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.195 个国家和地区 1990-2017 年炎症性肠病的全球、区域和国家负担:2017 年全球疾病负担研究的系统分析。
Lancet Gastroenterol Hepatol. 2020 Jan;5(1):17-30. doi: 10.1016/S2468-1253(19)30333-4. Epub 2019 Oct 21.
4
A review of the diagnosis, prevention, and treatment methods of inflammatory bowel disease.炎症性肠病的诊断、预防及治疗方法综述
J Med Life. 2019 Apr-Jun;12(2):113-122. doi: 10.25122/jml-2018-0075.
5
Heart Involvement in Inflammatory Rheumatic Diseases: A Systematic Literature Review.炎性风湿性疾病心脏受累:系统文献综述。
Medicina (Kaunas). 2019 Jun 6;55(6):249. doi: 10.3390/medicina55060249.
6
Cardiovascular Manifestations of Inflammatory Bowel Disease: Pathogenesis, Diagnosis, and Preventive Strategies.炎症性肠病的心血管表现:发病机制、诊断及预防策略
Gastroenterol Res Pract. 2019 Jan 13;2019:3012509. doi: 10.1155/2019/3012509. eCollection 2019.
7
The role of intestinal microbiota in cardiovascular disease.肠道微生物群在心血管疾病中的作用。
J Cell Mol Med. 2019 Apr;23(4):2343-2350. doi: 10.1111/jcmm.14195. Epub 2019 Feb 3.
8
Risk of Myocardial Infarction in Inflammatory Bowel Disease: A Population-based National Study.炎症性肠病患者心肌梗死的风险:一项基于人群的全国性研究。
Inflamm Bowel Dis. 2019 May 4;25(6):1080-1087. doi: 10.1093/ibd/izy354.
9
Atherosclerosis and inflammation: overview and updates.动脉粥样硬化与炎症:概述与最新进展
Clin Sci (Lond). 2018 Jun 21;132(12):1243-1252. doi: 10.1042/CS20180306. Print 2018 Jun 29.
10
Increased Intestinal Permeability and Decreased Barrier Function: Does It Really Influence the Risk of Inflammation?肠道通透性增加与屏障功能降低:这真的会影响炎症风险吗?
Inflamm Intest Dis. 2016 Oct;1(3):135-145. doi: 10.1159/000447252. Epub 2016 Jul 20.